Trustmark National Bank Trust Department’s GSK GSK Stock Holding History

Trustmark National Bank Trust Department’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.6M	Buy	29,071 +21,095	+264%	+$1.14M	0.1%	136
2025 Q4	$391K	Hold	7,976	–	–	0.02%	228
2025 Q3	$344K	Sell	7,976 -590	-7%	-$23K	0.02%	236
2025 Q2	$329K	Buy	8,566 +70	+0.8%	+$2.67K	0.02%	234
2025 Q1	$329K	Sell	8,496 -160	-2%	-$5.86K	0.02%	234
2024 Q4	$293K	Sell	8,656 -40,137	-82%	-$1.44M	0.02%	253
2024 Q3	$1.99M	Sell	48,793 -3,848	-7%	-$157K	0.15%	109
2024 Q2	$2.03M	Buy	52,641 +1,121	+2%	+$47.2K	0.16%	104
2024 Q1	$2.21M	Sell	51,520 -236	-0.5%	-$9.73K	0.18%	98
2023 Q4	$1.92M	Sell	51,756 -1,074	-2%	-$38.6K	0.17%	101
2023 Q3	$1.92M	Buy	52,830 +34,753	+192%	+$1.23M	0.19%	95
2023 Q2	$644K	Sell	18,077 -27,970	-61%	-$1M	0.06%	171
2023 Q1	$1.64M	Buy	+46,047	New	+$1.61M	0.15%	110
2022 Q3	–	Sell	-28,648	Closed	-$1.56M	–	259
2022 Q2	$1.56M	Sell	28,648 -738	-3%	-$40.7K	0.14%	110
2022 Q1	$1.6M	Sell	29,386 -45,779	-61%	-$2.49M	0.13%	115
2021 Q4	$4.14M	Sell	75,165 -6,964	-8%	-$362K	0.32%	78
2021 Q3	$3.92M	Buy	82,129 +63,441	+339%	+$3.19M	0.32%	78
2021 Q2	$930K	Buy	18,688 +10,888	+140%	+$523K	0.07%	147
2021 Q1	$348K	Sell	7,800 -5,426	-41%	-$246K	0.03%	205
2020 Q4	$608K	Sell	13,226 -8,518	-39%	-$391K	0.06%	164
2020 Q3	$1.02M	Sell	21,744 -8,742	-29%	-$438K	0.1%	121
2020 Q2	$1.55M	Sell	30,486 -175	-0.6%	-$8.98K	0.16%	94
2020 Q1	$1.45M	Sell	30,661 -1,909	-6%	-$102K	0.17%	96
2019 Q4	$1.91M	Sell	32,570 -17,845	-35%	-$993K	0.18%	96
2019 Q3	$2.69M	Sell	50,415 -16,511	-25%	-$849K	0.26%	78
2019 Q2	$3.35M	Sell	66,926 -3,869	-5%	-$194K	0.33%	63
2019 Q1	$3.7M	Sell	70,795 -6,385	-8%	-$319K	0.38%	60
2018 Q4	$3.69M	Sell	77,180 -514	-0.7%	-$25.3K	0.42%	57
2018 Q3	$3.9M	Sell	77,694 -365	-0.5%	-$18.5K	0.39%	57
2018 Q2	$3.93M	Sell	78,059 -6,442	-8%	-$324K	0.46%	51
2018 Q1	$4.13M	Buy	84,501 +33,715	+66%	+$1.57M	0.45%	54
2017 Q4	$2.25M	Buy	50,786 +18,506	+57%	+$855K	0.25%	89
2017 Q3	$1.64M	Buy	32,280 +20,815	+182%	+$1.06M	0.19%	101
2017 Q2	$618K	Buy	11,465 +1,338	+13%	+$71.3K	0.07%	161
2017 Q1	$534K	Buy	10,127 +3,373	+50%	+$171K	0.06%	166
2016 Q4	$325K	Sell	6,754 -2,382	-26%	-$118K	0.04%	202
2016 Q3	$493K	Sell	9,136 -5,427	-37%	-$298K	0.06%	178
2016 Q2	$789K	Sell	14,563 -6,357	-30%	-$335K	0.1%	151
2016 Q1	$1.06M	Buy	20,920 +1,983	+10%	+$98.8K	0.14%	127
2015 Q4	$956K	Buy	18,937 +1,048	+6%	+$53.4K	0.13%	136
2015 Q3	$860K	Buy	17,889 +4,507	+34%	+$235K	0.12%	154
2015 Q2	$697K	Buy	13,382 +936	+8%	+$52.7K	0.09%	180
2015 Q1	$718K	Buy	+12,446	New	+$714K	0.1%	184

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Trustmark National Bank Trust Department's GSK Position: Q1 2026 in Review

Trustmark National Bank Trust Department increased its GSK (GSK) stake by 264% in Q1 2026, buying an estimated $1.14M and bringing the position to 29,071 shares worth $1.6M. The position accounts for 0.1% of the portfolio, ranked #136.

Trustmark National Bank Trust Department first reported a position in GSK in Q1 2015 and has held it in 43 quarters since. The position peaked at $4.14M in Q4 2021. 1,034 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Trustmark National Bank Trust Department held 29,071 shares of GSK worth $1.6M as of Q1 2026.
Trustmark National Bank Trust Department bought 21,095 GSK shares in Q1 2026, an estimated $1.14M.
GSK made up 0.1% of Trustmark National Bank Trust Department's portfolio in Q1 2026, its #136 holding.
Trustmark National Bank Trust Department first reported a position in GSK in Q1 2015 and has held it in 43 quarters since.
Trustmark National Bank Trust Department's GSK position peaked at $4.14M in Q4 2021.
1,034 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Trustmark National Bank Trust Department's 13F filing for Q1 2026, filed 14 May 2026.